Ticker
OVIDCompany Name
OVID THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 77.43M | $ -38.18M | -49.31% |
3/31/2025 | $ 81.65M | $ -24.97M | -30.58% |
12/31/2024 | $ 92.17M | $ -26.43M | -28.68% |
9/30/2024 | $ 102.65M | $ -32.5M | -31.66% |
6/30/2024 | $ 118.09M | $ -29.75M | -25.19% |
3/31/2024 | $ 131.61M | $ -50.68M | -38.5% |
12/31/2023 | $ 144.03M | $ -52.34M | -36.34% |
9/30/2023 | $ 125.03M | $ -48.52M | -38.81% |
6/30/2023 | $ 136.23M | $ -49.24M | -36.14% |
3/31/2023 | $ 143.37M | $ -51.42M | -35.86% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for OVID THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -75.98M ] / Assets [ $ 91.6M ]
(=) ROA [ -82.94% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.4% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.61% |